Sort
82,697 grants matching “vaccine development”
Building a Predictive Framework for Adjuvant Combinatorics in Vaccine Development
$2,430,000Nicolas Chevrier · University Of Chicago · DP2 · FY2018 · AI
Task V07: Immunogenicity and efficacy testing of COVID-19 vaccine candidates in nonhuman primates
$2,429,847Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
Durban International Clinical Trials Unit
$2,429,118Umesh G Lalloo · Ukzn Innovation · U01 · FY2011 · AI
Case Clinical Trials Unit
$2,428,514George Yendewa · Case Western Reserve University · UM1 · FY2025 · AI
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
$2,428,494Colleen B Jonsson · University Of Tennessee Health Sci Ctr · UC7 · FY2025 · AI
PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)
$2,427,282Robert Miller · Johns Hopkins University · N01 · FY2018 · AI
Enhanced Surveillance for New Vaccine Preventable Diseases
$2,426,950Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2018 · IP
Pre-clinical Vaccine Development for Respiratory Viruses
$2,426,352Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,425,739Scott M Hammer · Columbia University Health Sciences · UM1 · FY2013 · AI
Adolescent Trials Network for HIV/AIDS Intervention
$2,425,648Westat, Inc. · U01 · FY2003 · HD
Vaccine Induced Immunity in the Young and Aged
$2,425,378Rafi Ahmed · Emory University · U19 · FY2019 · AI
The Genome Analysis Core
$2,424,710Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
ACO/Public Health Collaborative Preventive Care Delivery to Priority Populations
$2,424,597Allison Kempe · University Of Colorado Denver · R18 · FY2013 · HS
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,424,537Rachel R. Caspi · National Eye Institute · ZIA · FY2014 · EY
Genetic Analysis of T-cell Differentiation
$2,424,498Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Spore in Head and Neck Cancer
$2,424,440David Sidransky · Johns Hopkins University · P50 · FY2012 · DE
Synthetic DNA-launched and adjuvanted Env immunogens for HIV
$2,424,072David B. Weiner · Wistar Institute · U19 · FY2025 · AI
Optimization Of HIV Specific Immune Responses In Vivo
$2,423,669Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
$2,423,115Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2016 · CA
A Gene therapeutic approach to stable suppression of HIV-1 replication
$2,422,882Michael R. Farzan · Scripps Florida · P01 · FY2015 · AI
Alabama-Clinical Trials Unit
$2,421,303Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2007 · AI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES
$2,420,364Barbara Driver · Westat, Inc. · N01 · FY2023 · HD
Non-Human Primate Discovery Team
$2,420,318Norman L Letvin · Duke University · U19 · FY2010 · AI
Influenza and Emerging Infectious Diseases
$2,420,158Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$2,420,050Ronald Brown · Quality Biological, Inc. · N01 · FY2012 · AI